Christel Kolodziejczak
About Christel Kolodziejczak
Christel Kolodziejczak is a Deleguee Hospitaliere Immuno Oncologie at Bristol-Myers Squibb, with over 24 years of experience in the pharmaceutical industry, based in Lille, France.
Current Position at Bristol-Myers Squibb
Christel Kolodziejczak is currently serving as Deleguee Hospitaliere Immuno Oncologie at Bristol-Myers Squibb. She operates in the Nord region, specifically based in Lille, France. Her role focuses on advancing immuno-oncology treatments, contributing significantly to the healthcare sector in this area. Her transition to this role in 2015 marked a shift to a specialized field within the pharmaceutical industry.
Previous Role in Cardiovascular Specialization
Before her current position, Christel Kolodziejczak worked as a Deleguee Hospitaliere Cardiovasculaire at Bristol-Myers Squibb. She held this position for 16 years, from 1999 to 2015. During this period, she gained substantial experience in the cardiovascular sector, contributing to the advancement of cardiovascular treatments and therapies in her region.
Career in Immuno-Oncology
Since April 2015, Christel Kolodziejczak has been working in the field of immuno-oncology. Her switch from cardiovascular to immuno-oncology indicates a dynamic and adaptive career path. She has focused on developing and promoting treatments that leverage the body's immune system to fight cancer, aligning with the innovative approaches characteristic of Bristol-Myers Squibb.
Experience in the Pharmaceutical Industry
Christel Kolodziejczak brings over 24 years of experience in the pharmaceutical industry. Her extensive career spans significant roles and responsibilities, showcasing her ability to adapt and excel in various specialized fields. Her contributions have been instrumental in both cardiovascular and immuno-oncology disciplines.